
Most cases of leukemia occur in older adults, with more than half occurring after age 64. Leukemia is expected to strike more than nine times as many adults as children.
Even so, leukemia accounts for nearly a third of cancers in children between birth and age 14. The disease causes more deaths than any other cancer among children and young adults under the age of 20. Survival rates for children with leukemia have dramatically increased over the past 30 years.
An estimated 35,000 new cases of leukemia are diagnosed annually.
Under the leadership of Michael Lill, MD, Medical Director of the Blood and Marrow Transplant Program at Cedars-Sinai, a multidisciplinary team of experts provides advanced, comprehensive care to patients with leukemia.
Because leukemia causes an uncontrolled growth of blood cells that are not mature, the first step in diagnosing leukemia is a blood count.
Depending on the results of this test, the next step may be to do a bone marrow biopsy. In this test, the patient is under anesthesia while a large needle is inserted into the bone to remove a small sample of bone marrow. The sample is looked at under a microscope to see if abnormal cells are present. A biopsy also sometimes shows defects in genetic materials (chromosomes) that are linked to certain forms of leukemia.
The biopsy allows a doctor to determine what type of leukemia is present and design the most effective treatment.
The goal of treatment is to bring about complete remission. This means that there is no evidence of the disease and the patient is able to return to good health with normal blood and marrow cells. If a person stays in remission for five years after treatment, he or she is considered cured.
The approach to treating leukemia is different for each major type of leukemia.
© Copyright 2000-2009 Cedars-Sinai Health System.
All
rights reserved.
Privacy Policy
Terms and Conditions
